This prospective, multicenter, randomized controlled trial published in the American Journal of Kidney Diseases (AJKD) demonstrated that, compared with a reactive strategy of potassium supplementation ...
MADRID, Spain—Increasing low potassium levels improves clinical outcomes among patients with cardiovascular disease and a high risk for ventricular arrhythmias, the randomized POTCAST trial shows.